Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

28 trials with published results (9%)

Research Maturity

166 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

17 terminated out of 302 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

23%

69 trials in Phase 3/4

Results Transparency

17%

28 of 166 completed with results

Key Signals

28 with results91% success17 terminated

Data Visualizations

Phase Distribution

182Total
Not Applicable (52)
Early P 1 (3)
P 1 (37)
P 2 (21)
P 3 (30)
P 4 (39)

Trial Status

Completed166
Unknown61
Recruiting29
Terminated17
Not Yet Recruiting14
Active Not Recruiting8

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 166 completed trials

Clinical Trials (302)

Showing 20 of 20 trials
NCT06993740Not ApplicableCompleted

Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

NCT07137429RecruitingPrimary

Platelet Volunteers, Longitudinal and Multi-omic Study

NCT03161678Phase 4Completed

CES1 Crossover Trial of Clopidogrel and Ticagrelor

NCT07597239Not ApplicableActive Not RecruitingPrimary

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

NCT06329921Not ApplicableEnrolling By Invitation

Inpatient Monitoring of Unfractionated Heparin

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT06370273Phase 3RecruitingPrimary

Thromboprophylaxis in Lower Limb Immobilisation

NCT06694779Completed

Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study

NCT07580469Not Yet Recruiting

Platelets and Extracorporeal Membrane Oxygenation Veno-venous

NCT06357403RecruitingPrimary

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

NCT07644247Phase 4Not Yet Recruiting

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

NCT07643246Not Yet RecruitingPrimary

National Study on the Prevalence of Catheter-Related Venous Thrombosis

NCT07632976Phase 1Active Not Recruiting

A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis

NCT07618351Phase 1CompletedPrimary

A Phase I SAD/MAD and Liver Effect Study of Vitalangio in Venous Thromboembolism Patients .

NCT07613840Not ApplicableRecruiting

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

NCT04262492Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

NCT06618976Phase 4CompletedPrimary

Antithrombotic Activities of Sotagliflozin vs. Empagliflozin

NCT06820515Recruiting

ATHNdataset Registry

NCT07519304Not ApplicableNot Yet Recruiting

Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Venous Catheters in Hospitalised Adult Patients: Randomised Clinical Trial

NCT07523880RecruitingPrimary

Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD

Scroll to load more

Research Network

Activity Timeline